Jefferies Group LLC Cassava Sciences Inc Put Options Transaction History

Jefferies Group LLC

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Sep 21, 2023	SELL	$16.33 - $51.06 $4.35 Million - $13.6 Million	-266,100 Reduced 39.76%	403,100 $16.9 Million
Q3 2022 Nov 14, 2022	SELL	$16.33 - $51.06 $4.35 Million - $13.6 Million	-266,100 Reduced 39.76%	403,100 $16.9 Million
Q2 2022 Sep 21, 2023	BUY	$17.22 - $38.47 $4.03 Million - $9.01 Million	234,300 Added 53.87%	669,200 $18.8 Million
Q2 2022 Aug 15, 2022	BUY	$17.22 - $38.47 $4.03 Million - $9.01 Million	234,300 Added 53.87%	669,200 $18.8 Million
Q1 2022 Sep 21, 2023	BUY	$32.6 - $53.05 $10.9 Million - $17.8 Million	334,900 Added 334.9%	434,900 $16.2 Million
Q1 2022 May 16, 2022	BUY	$32.6 - $53.05 $14.2 Million - $23.1 Million	434,900 New	434,900 $16.2 Million
Q4 2021 Feb 14, 2022	SELL	$36.77 - $90.91 $3.68 Million - $9.09 Million	-100,000 Closed	0 $0
Q3 2021 Sep 21, 2023	BUY	$41.79 - $135.3 $3.55 Million - $11.5 Million	85,000 Added 566.67%	100,000 $6.21 Million
Q3 2021 Nov 15, 2021	BUY	$41.79 - $135.3 $3.55 Million - $11.5 Million	85,000 Added 566.67%	100,000 $6.21 Million
Q2 2021 Sep 21, 2023	SELL	$32.15 - $89.72 $12.5 Million - $34.8 Million	-388,100 Reduced 96.28%	15,000 $1.28 Million
Q2 2021 Aug 20, 2021	SELL	$32.15 - $89.72 $47.7 Million - $133 Million	-1,485,000 Reduced 99.0%	15,000 $1.28 Million
Q2 2021 Aug 16, 2021	BUY	$32.15 - $89.72 $48.2 Million - $135 Million	1,500,000 New	1,500,000 $1.28 Million

184

13.3M

1.38M

2.04M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $1.18B
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.